HCC |
Hepatocellular carcinoma |
miRNAs |
MicroRNAs |
KEGG |
Kyoto Encyclopedia of Genes and Genomes |
ncRNAs |
Non-coding RNA |
TCGA |
The Cancer Genome Atlas |
GTEx |
Genotype-Tissue Expression |
BLCA |
Bladder urothelial carcinoma |
BRCA |
Breast invasive carcinoma |
CESC |
Cervical squamous cell carcinoma and Endocervical adenocarcinoma |
CHOL |
Cholangiocarcinoma |
COAD |
Colon adenocarcinoma |
ESCA |
Esophageal carcinoma |
GBM |
Glioblastoma multiforme |
HNSC |
Head and neck squamous cell carcinoma |
KICH |
Kidney chromophobe |
KIRC |
Kidney renal clear cell carcinoma |
KIRP |
Kidney renal papillary cell carcinoma |
LIHC |
Liver hepatocellular carcinoma |
LUAD |
Lung adenocarcinoma |
LUSC |
Lung squamous cell carcinoma |
PAAD |
Pancreatic adenocarcinoma |
PCPG |
Pheochromocytoma and paraganglioma |
PRAD |
Prostate adenocarcinoma |
READ |
Rectum adenocarcinoma |
STAD |
Stomach adenocarcinoma |
THCA |
Thyroid carcinoma |
UCEC |
Uterine corpus endometrial carcinoma |
HBV |
Hepatitis B virus |
HCV |
Hepatitis C virus |
EZH2 |
Enhancer of Zeste Homolog 2 |
PcG |
Polycomb group |
NCBI |
National Center for Biotechnology Information |
HPA |
Human Protein Atlas |
FC |
Fold change |
OS |
Overall survival |
DFS |
Disease-free survival |
K-M |
Kaplan-Meier |
DSS |
Disease-specific survival |
PFI |
Progression-free interval |
GSEA |
Gene set enrichment analysis |
CeRNA |
Competing endogenous RNA |
CAFs |
Cancer-associated fibroblasts |
TME |
Tumor microenvironment |
ICB |
Immune checkpoint inhibitors |